After purchasing Lasentec® in 2001, METTLER TOLEDO has become the world leader for in-line particle/droplet size, shape, and count characterization.
Learn how automated lab reactors and in-situ PAT enabled rapid process scale-up of PEG-lipid nanoparticle (LNP) formulation for mRNA vaccines during the COVID-19 pandemic.